Search Results 501-510 of 24096 for autoimmune hepatitis

1. Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   ... liver disease, hepatitis B, hepatitis C, autoimmune disorders (eg, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis), drug ...

2. Fatty liver disease (MASLD) - Doctors and departments - Mayo Clinic

   This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

3. Patrick S. Kamath, M.D. - Doctors and Medical Staff - Mayo Clinic

   ... liver disease, Fontan Associate Liver Disease, and vascular diseases of the liver. Conditions treated · Alcoholic hepatitis; Alcoholic liver disease; Ascites ...

4. Mayo Clinic Transplant Center - Doctors

   langitis, Portal hypertension, Hemochromatosis, Alcoholic hepatitis, Autoimmune hepatitis, Primary biliary cholangitis, Biliary atresia, Hepatic encephalopathy.

5. Genetics of Liver Disease: Kirk J. Wangensteen - Mayo Clinic Research

   Research in Mayo Clinic's Genetics of Liver Disease Lab focuses on genetic factors involved in liver disease progression and liver cancer development.

6. Education and training - Genetics of Liver Disease: Kirk J. Wangensteen - Mayo Clinic Research

   Learn about available training opportunities in the Genetics of Liver Disease Lab led by Kirk J. Wangensteen, M.D., Ph.D., at Mayo Clinic's campus in ...

7. Multi-phase Dual Energy for Quantitative and Radiologic Evaluation of Chronic Liver Disease - Mayo Clinic

   The purpose of this study is to assess the combined impact of post-processing methods that quantify potential biomarkers of chronic liver disease (AEF, fECS) ...

8. Transplant Medicine Calculators - Medical Professionals - Mayo Clinic

   The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease ... MELD Score and ...

9. Ribavirin (oral route) - Side effects & dosage - Mayo Clinic

   Autoimmune hepatitis (liver inflammation) or; Heart disease (unstable), or history of or; Kidney disease, severe or; Liver disease (including cirrhosis), severe ...

10. Phase 2a, Dose-ranging Study With PF-05221304 In Nonalcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    Phase 2a, Dose-ranging Study With PF-05221304 In Nonalcoholic Fatty Liver Disease (NAFLD) · Overview · Participation eligibility · Participating Mayo Clinic ...